nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A child with acquired Gerbode defect due to infective endocarditis: Successful percutaneous closure with Nit-occlud device®
|
Éden Santos, P. |
|
2018 |
49 |
C |
p. 77-80 |
artikel |
2 |
A dynamic risk management approach to reduce harm in hypertrophic cardiomyopathy
|
Friedberg, Mark K. |
|
2018 |
49 |
C |
p. 12-17 |
artikel |
3 |
An atypical right ventricle-dependent coronary circulation in a child with pulmonary artery stenosis
|
Tahhan, Nabil |
|
2018 |
49 |
C |
p. 74-76 |
artikel |
4 |
Cardiac rehabilitation in pediatric cardiomyopathy
|
Thrush, Philip T. |
|
2018 |
49 |
C |
p. 43-46 |
artikel |
5 |
Circulating microRNAs as biomarkers in pediatric heart diseases
|
Sucharov, Carmen C. |
|
2018 |
49 |
C |
p. 50-52 |
artikel |
6 |
Differential response to heart failure medications in children
|
Miyamoto, Shelley D. |
|
2018 |
49 |
C |
p. 27-30 |
artikel |
7 |
Early complete atrioventricular block after percutaneous closure of a perimembranous ventricular septal defect with a Nit-Occlud (®) Lê VSD coil
|
Sanz, Ana Pardo |
|
2018 |
49 |
C |
p. 81-83 |
artikel |
8 |
Genetics of pediatric cardiomyopathies
|
Chung, Wendy K. |
|
2018 |
49 |
C |
p. 18-19 |
artikel |
9 |
Implantable cardioverter defibrillators and biventricular pacing in pediatric dilated cardiomyopathy: Preventing death and delaying heart transplant
|
Kumthekar, Rohan |
|
2018 |
49 |
C |
p. 38-42 |
artikel |
10 |
Introduction
|
Lipshultz, Steven E. |
|
2018 |
49 |
C |
p. 1 |
artikel |
11 |
Neurohormonal targets in the treatment of pediatric heart failure
|
Edelson, Jonathan B. |
|
2018 |
49 |
C |
p. 2-8 |
artikel |
12 |
Obstacles to prediction of outcome in pediatric cardiomyopathy
|
Colan, Steven D. |
|
2018 |
49 |
C |
p. 9-11 |
artikel |
13 |
Postoperative complete heart block among congenital heart disease patients: Contributing risk factors, therapies and long-term sequelae in the current era
|
Garcia, Richard U. |
|
2018 |
49 |
C |
p. 66-70 |
artikel |
14 |
Psychological impact of sports restriction in asymptomatic adolescents with hypertrophic cardiomyopathy, dilated cardiomyopathy, and long QT syndrome
|
Berg, Alizabeth E. |
|
2018 |
49 |
C |
p. 57-62 |
artikel |
15 |
QTc prolongation with energy drinks comparable to moxifloxacin
|
McGaughey, Tracey J. |
|
2018 |
49 |
C |
p. 63-65 |
artikel |
16 |
Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?
|
Nakano, Stephanie J. |
|
2018 |
49 |
C |
p. 31-37 |
artikel |
17 |
Stenting of the right ventricular outflow tract after late thrombosis of a modified Blalock-Taussig shunt in an infant with tetralogy of Fallot and right pulmonary artery agenesis
|
Soynov, Ilya |
|
2018 |
49 |
C |
p. 71-73 |
artikel |
18 |
Targeting protein kinase C: A novel paradigm for heart failure therapy
|
Jefferies, John Lynn |
|
2018 |
49 |
C |
p. 53-56 |
artikel |
19 |
Towards a learning system for pediatric outcomes: Harvesting meaning from evidence
|
Kleinman, Lawrence C. |
|
2018 |
49 |
C |
p. 20-26 |
artikel |
20 |
Utilization of VADs in children with restrictive and hypertrophic cardiomyopathy: Are we there yet?
|
Villa, Chet |
|
2018 |
49 |
C |
p. 47-49 |
artikel |